About this trial
* Detection of sensitivity and specificity of microscopic examination and Molecular studies using polymerase chain reaction (PCR) Mycobacterium tuberculosis (MTB)/ non tuberculous mycobacterium (NTM) MDR-TB compared to culture which is the gold standard technique in the diagnosis of TB to reach the most reliable one for better health care service. * Assess the prevalence of tuberculosis cases among clinically suspected cases admitted to the hospital throughout the selected study period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with signs and symptoms of tuberculosis (suspected cases)
Patients diagnosed with tuberculosis.
Disqualifiers
Patients with pulmonary infections other than TB
Trial population
Patients with signs and symptoms of tuberculosis (suspected cases) and Patients diagnosed with tuberculosis of both sexes admitted to Assiut university hospitals
Trial design
Other
Cross-sectional
Treatments tested in this trial
PCR MTB/NTM
Diagnostic test• The Polymerase chain reaction (PCR) MTB/NTM MDR-TB test is an innovative technology that offers a cutting-edge approach to the precise diagnosis of tuberculosis and nontuberculous mycobacterial infections (NTM).
Treatment groups
Trial outcomes
Primary outcomes
*Compare between different available tests to reach the most reliable one for better health care service.
\*Detection of sensitivity and specificity of microscopic examination and Molecular studies using PCR MTB/NTM MDR-TB compared to culture which is the gold standard technique in the diagnosis of TB to reach the most reliable one for better health care service.
Secondary outcomes
*Assess the prevalence of tuberculosis cases among clinically suspected cases admitted to the hospital throughout the selected study period.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: